rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-5-18
|
pubmed:databankReference |
|
pubmed:abstractText |
Continuous dopaminergic drug delivery is an unmet medical need in advanced Parkinson's disease. The aim of this trial-Clinical Efficacy of Pramipexole And Transdermal Rotigotine in Advanced PD (CLEOPATRA-PD)-was to assess the efficacy of adjunct treatment with rotigotine in comparison with placebo and with pramipexole in levodopa-treated patients with advanced Parkinson's disease and wearing-off type motor fluctuations.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1474-4422
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
513-20
|
pubmed:dateRevised |
2008-1-23
|
pubmed:meshHeading |
pubmed-meshheading:17509486-Administration, Cutaneous,
pubmed-meshheading:17509486-Aged,
pubmed-meshheading:17509486-Antiparkinson Agents,
pubmed-meshheading:17509486-Benzothiazoles,
pubmed-meshheading:17509486-Dopamine Agonists,
pubmed-meshheading:17509486-Double-Blind Method,
pubmed-meshheading:17509486-Female,
pubmed-meshheading:17509486-Humans,
pubmed-meshheading:17509486-Male,
pubmed-meshheading:17509486-Middle Aged,
pubmed-meshheading:17509486-Parkinson Disease,
pubmed-meshheading:17509486-Placebos,
pubmed-meshheading:17509486-Severity of Illness Index,
pubmed-meshheading:17509486-Tetrahydronaphthalenes,
pubmed-meshheading:17509486-Thiophenes,
pubmed-meshheading:17509486-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.
|
pubmed:affiliation |
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. werner.poewe@i-med.ac.at
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|